Could the risks of cholesterol-lowering statins outweigh the benefits? Is the research on these drugs fatally biased, as it was funded and carried out by statin manufacturers in a way that would be “totally unacceptable” today?
That’s what a new study claims. The UK Queen’s former doctor is calling for an independent inquiry – and here’s what UK cardiologist Dr. Aseem Malhotra says:
These are truly disturbing findings and fit in with the concept that all industry-sponsored studies should be seen as marketing until proven otherwise.